Navigation Links
Neurologix Completes Additional $7 Million Financing
Date:12/6/2010

FORT LEE, N.J., Dec. 6, 2010 /PRNewswire-FirstCall/ -- Neurologix, Inc. (OTC Bulletin Board: NRGX), a biotechnology company developing innovative gene therapies for disorders of the brain and central nervous system, today announced that it has received additional financing from three of its largest existing investors, or their affiliates: Corriente Advisors; GE Pension Trust; and Palisade Capital Management, LLC. These investors have provided a loan to Neurologix in the aggregate principal amount of $7 million.

The loan bears interest at 10% per annum, matures on October 31, 2011, and is secured by substantially all the assets of the Company. At maturity, the Company will pay an amount equal to 1.2 times the principal amount of the loan, plus accrued interest. In addition, the investors received 7-year warrants exercisable for an aggregate of 2,430,555 shares of the Company's common stock at an exercise price of $1.44 per share. The investors were granted certain preemptive rights with respect to future financings of the Company and were granted certain registration rights with respect to the shares of the Company's common stock issuable on exercise of their warrants. The loan will be automatically converted into the preferred stock issued by the Company upon a subsequent preferred equity financing of $30 million or more. MTS Securities, LLC acted as lead placement agent on the financing and Trout Capital LLC acted as an additional placement agent.

"This additional financing reflects the strong support we have from our largest shareholders and the confidence they have in our strategy, technology and ability to bring our novel Parkinson's gene therapy to market, " said Clark A. Johnson, President and Chief Executive Officer of Neurologix. "We continue to advance NLX-P101 toward commercialization and will seek additional funding to prepare for and support a pivotal Phase
'/>"/>

SOURCE Neurologix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Details Presented at the World Parkinson Congress on Neurologixs Successful Phase 2 Trial of Gene Therapy for Parkinsons Disease
2. Research Published in Science Translational Medicine Underscores Value of Depression Gene Therapy License Held by Neurologix
3. Neurologix Reports Third Quarter 2010 Financial Results
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
7. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. QuatRx Completes Patient Enrollment in Phase 3 Study of Ophena(TM) in Women with Postmenopausal Vaginal Syndrome
10. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
11. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 10, 2014  Decision Resources Group finds that ... (ID) specialists are willing to prescribe Durata,s Dalvance ... use as OPAT, approximately two-thirds of the respondents ... their hospital inpatients. However, our findings indicate that ... initiated on OPAT following hospital discharge, and most ...
(Date:1/15/2014)... /PRNewswire-iReach/ -- ChinaMarketResearchReports.com adds "China Orthopedic Instrument Industry Report, ... (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ) Benefiting from ... China,s orthopedic instrument industry has seen ... rising from 3.28 billion yuan in 2006 to 9.85 ...
(Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading health ... several new IT value-added reseller (VAR) national contracts that ... goods and services at lower costs. These include manufacturer ... such as initiative assistance and ongoing IT consulting support. ...
Breaking Medicine Technology:Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2
(Date:7/10/2014)... than 200 experts on aggression, who research issues ranging ... the 21st World Meeting of the International Society ... Atlanta Hotel, July 15-19. , Georgia State University ... held every other year on alternating continents. , "We ... more than 20 different countries, which will help produce ...
(Date:7/10/2014)... Ticketability.com has a wide array of tickets ... tickets for San Diego are being added to the inventory. ... and the newly added September 28 show is drawing a ... Here to view the selection of discounted seats at ... become available to the general public on July 18 at ...
(Date:7/10/2014)... 2014 One week ahead of its ... announced today it will extend compensation benefits to workers ... for workers displaced as a result of factory remediation, ... have resulted in the closure of five factories for ... raising immediate safety concerns. In May, the Alliance—in a ...
(Date:7/10/2014)... 11, 2014 According to a ... by Platforms (Land, Airborne, Naval), Application (Software Defined ... by Geography (North America, Asia-Pacific, Europe, the Middle ... published by MarketsandMarkets, the market is estimated to ... to register a CAGR of 5.56% to reach ...
(Date:7/10/2014)... In his latest blog post at ... facility CEO Per Wickstrom has listed 5 ways to ... confirm an appointment, get information or sometimes even just ... being annoying is a skill that most people don’t ... to keep the dialogue moving without coming across as ...
Breaking Medicine News(10 mins):Health News:Georgia State Hosts National Conference On Aggression 2Health News:Georgia State Hosts National Conference On Aggression 3Health News:Georgia State Hosts National Conference On Aggression 4Health News:Paul McCartney Tickets for San Diego: Ticketability.com Announces Discounted Tickets for McCartney’s Tour Stop at Petco Park on September 28 2Health News:Alliance for Bangladesh Worker Safety to Double Compensation for Displaced Factory Workers; Members Vote to Extend Wage Benefits from Two to up to Four Months 2Health News:Portable Communication Systems Market Projected to Reach $39.52 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Portable Communication Systems Market Projected to Reach $39.52 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Portable Communication Systems Market Projected to Reach $39.52 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Per Wickstrom’s Latest Blog Post Lists 5 Ways to Follow-up Without Being Annoying 2
... available everywhere in the Wadden Sea so you have to search ... where is the best place to go? Initially the food rich ... can find other animals of course and that gives rise to ... to consume the prey caught. , Takeaway meal , ...
... leading cause of adult-onset blindness, experts note , TUESDAY, Sept. ... their vision checked if they have access to health care, ... experts say. , However, minorities with diabetes or people living ... even when they know why it is important to do ...
... magnetic resonance imaging (fMRI) have found a new marker ... according to a study published in the October issue ... a potential functional, rather than structural, brain markerseparate from ... Alzheimers patients, said the studys lead author, Jeffrey R. ...
... BOTHELL, Wash., Sept. 25 Cardiac Science,Corporation ... in advanced cardiac monitoring,and defibrillation products, today ... other lay rescuers from the Pittsburgh school ... defibrillator,(AED). (Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO ) ...
... for research to improve health and welfare of ... companion animals and wildlife, ... for individuals or groups to demonstrate love,for and help animals via ... about 120 animal health studies available,for sponsorship. Animal lovers are invited ...
... ... Program Oct. 1, MINNEAPOLIS and ST. PAUL, ... Minnesota,s major health plans and,ClearWay Minnesota(SM) -- is launching a new program ... patients who,want to stop smoking. The Minnesota Clinic Fax Referral Program begins,October ...
Cached Medicine News:Health News:Regular Eye Screens Spot Diabetic Vision Trouble 2Health News:Radiologists identify early brain marker of Alzheimer's disease 2Health News:Radiologists identify early brain marker of Alzheimer's disease 3Health News:Cardiac Science Applauds Mass AED Training of Pittsburgh Educators 2Health News:Cardiac Science Applauds Mass AED Training of Pittsburgh Educators 3Health News:Cardiac Science Applauds Mass AED Training of Pittsburgh Educators 4Health News:Morris Animal Foundation 2008 Sponsorship Guide Available, Details Current Animal Health Studies 2Health News:Morris Animal Foundation 2008 Sponsorship Guide Available, Details Current Animal Health Studies 3Health News:Health Organizations Join Forces Around Quit-Smoking Help 2
Nasal Implants are used to augment the shape or reshaping of the nose....
... PTFE facial implant is an expanded ... augmentation or repair of the soft ... is available in sheets and shaped ... round facial implant strands are packaged ...
Inquire...
The MiniMed Paradigm REAL-Time System is the world's first system to integrate an insulin pump with REAL-Time continuous glucose monitoring, taking diabetes management to a level you just can't achie...
Medicine Products: